3.16
price down icon10.73%   -0.38
after-market Handel nachbörslich: 3.17 0.010 +0.32%
loading

Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
17.52%
5.732
4.8774 3.5236 5.1903 4.2863
Operating Income/Loss
17.52%
-5.732
-4.8774 -3.5236 -5.1903 -4.2863
Income/Loss From Continuing Operations Before Tax
29.98%
-5.4408
-4.1859 -3.1615 -4.7464 -3.8678
Income/Loss From Continuing Operations After Tax
29.98%
-5.4408
-4.1859 -3.1615 -4.7464 -3.8678
Net Income/Loss
29.98%
-5.4408
-4.1859 -3.1615 -4.7464 -3.8678
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
72,760%
10.74
-0.0148 10.86 10.86 10.86
Diluted Average Shares
72,760%
10.74
-0.0148 10.86 10.86 -
Basic Earnings Per Share
30.77%
-0.51
-0.39 -0.29 -0.44 -0.36
Diluted Earnings Per Share
30.77%
-0.51
-0.39 -0.29 -0.44 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):